Table 1 Linkage groups generated
LGParent A cMParent B cMCross MarkersScaffoldsMbKey Loci
I14.92.17,9542,27563.410prx621a, infPhoxa, Integrin α-3 precursorb, ferritinc, BgGRNd
II72.337.22,5821,27844.126Coagulation factor XIb, BgCREBe
III31.959.63,9011,267.542.570tal1–100a, Galectin-IIab, p63f
IV23.481.94,1541,835.538.203Peptidoglycan recognition proteinb
V58.520.22,78996536.603actinc, gpx65a, gpx97a, prx1a, Galectin-IIIab, frep1g
VI38.357.45,0201,65933.382phox22a, Inter α-trypsin inhibitorb, Cystatinb, LBP/BPIb, β-1,3-glucanaseb
VII35.131.93,0751,12729.802RADresh, BgSTAT1e, BgSTAT2e
VIII40.454.32,6851,08028.083frep5g, frep7g, hcl-2i
IX62.848.91,36259226.313Guadeloupe Resistance Complex (including grctm6)j,k, BgTLRl, spondin-1b, sod1m,n, bmplysh,o, prx4a,n (Figure 5)
X7.428.72,9301,190.524.348frep3p, frep4g, frep11g, duox584a
XI75.539.42,168669.522.606nox2a, BgRelishe
XII73.422.32,14496122.396hsp70c, RAPD QTLq
XIII59.664.92,197900.522.389gpx2404a, Matrilinb, Theromacinb
XIV56.435.11,062562.517.916Metalloproteinaseb
XV29.831.91,263449.517.663
XVI001,300621.514.697
XVII37.245.789441512.792Serine protease inhibitorb
XVIII21.314.91,307540.512.782
XIX3.20122941.407
XX00181261.286
XI5.3086401.276
XII001118.50.469
XIII0061330.323
XIV005120.210
Total746.7676.449,25318,613515.053
  • LG, linkage group; Parent A cM, genetic distance spanned by parent A markers in centimorgans; Parent B cM, genetic distance spanned by parent B markers in centimorgans; Cross Markers, number of markers used in linkage cross map (LD markers not included); Scaffolds, total number of scaffolds in final LG (some scaffolds are split among LGs, so totals are not integers); Mb, combined size of all scaffolds in final LG in megabases; Key Loci, notable or representative loci found on LG. LD, linkage disequilibrium.

  • a Larson et al. (2014).

  • b Mitta et al. (2005).

  • c Adema et al. (2017).

  • d Pila et al. (2016b).

  • e Zhang and Coultas (2011).

  • f Baričević et al. (2015).

  • g Léonard et al. (2001).

  • h Tennessen et al. (2015b).

  • i Peña and Adema (2016).

  • j Tennessen et al. (2015a).

  • k Allan et al. (2017).

  • l Pila et al. (2016a).

  • m Goodall et al. (2006).

  • n Blouin et al. (2013).

  • o Galinier et al. (2013).

  • p Hannington et al. (2012).

  • q Knight et al. (1999).